Moolec Science SA Calls Shareholder Meetings for Dec 27

Ticker: MLECW · Form: 6-K · Filed: Dec 13, 2024 · CIK: 1937737

Sentiment: neutral

Topics: corporate-governance, shareholder-meeting, restructuring

TL;DR

Moolec Science SA holding shareholder meetings Dec 27 to vote on moving its central administration.

AI Summary

Moolec Science SA has issued a 6-K filing on December 13, 2024, announcing its Annual General Meeting and Extraordinary General Meeting scheduled for December 27, 2024. A key item for the Extraordinary General Meeting is the approval of the transfer of the company's central administration.

Why It Matters

This filing signals a significant corporate restructuring event, specifically the potential relocation of the company's central administration, which could impact its operational and legal framework.

Risk Assessment

Risk Level: medium — The transfer of central administration is a significant corporate action that could have implications for operations, governance, and regulatory compliance.

Key Players & Entities

FAQ

What is the purpose of the Annual General Meeting and Extraordinary General Meeting?

The meetings are being held to discuss and vote on various company matters, including the approval of the transfer of the company's central administration.

When and where will the shareholder meetings take place?

The meetings are scheduled for December 27, 2024, at 2:30 p.m. Central European Time, at 35, avenue J. F. Kennedy, L-1855 Luxembourg, Grand Duchy of Luxembourg.

What is a primary item on the agenda for the Extraordinary General Meeting?

A primary item is the approval of the transfer of Moolec Science SA's central administration.

What type of report is this filing?

This is a Form 6-K, Report of Foreign Private Issuer.

Under which rules is this report filed?

This report is filed pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934.

Filing Stats: 372 words · 1 min read · ~1 pages · Grade level 13.7 · Accepted 2024-12-13 16:24:51

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. MOOLEC SCIENCE SA (Registrant) Dated: December 13, 2024 By: /s/ Gastón Paladini Name: Gastón Paladini Title: Chief Executive Officer 3

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing